Heritage of Discovery
OphthaFund was founded by experienced ophthalmic clinicians, investors, and business leaders. Our relationship-driven approach gives us access to promising opportunities across ophthalmic biotechnology, medical devices, and clinical research tools. We combine scientific rigor, clinical perspective, and operating experience to help advance technologies that can improve eye care.
Relationship-Driven Opportunities
Our network includes clinicians, scientists, entrepreneurs, industry executives and investors. Many of the opportunities we evaluate originate through these relationships, providing access to companies, technologies and informed perspectives developed over years.
Our Investment Approach
Our approach is grounded in experience developed through evaluating, investing in and working with emerging healthcare companies. We draw on the experience of our partners, advisors and broader network when specialized perspective is useful. We invest across stages and technologies rather than following a rigid formula. We seek opportunities where our experience gives us conviction that a technology addresses an important problem and has the potential to create both clinical and investment value.
Beyond Capital
Portfolio companies may benefit from clinical expertise, industry relationships and strategic guidance. When appropriate, our partners contribute through advisory roles, strategic and financing support, and board participation.
Our Focus
Our primary focus is ophthalmology and eye care. We consider therapeutics, medical devices, diagnostics and imaging, surgical technologies, drug delivery, digital solutions, clinical research tools and platforms, and other innovations. Our decisions are driven by the quality of the opportunity rather than a predetermined technology category or development stage.
Our Vision & Values
Scientific Excellence
We evaluate opportunities with scientific rigor and clinical perspective.
Medical Innovation
We support technologies with the potential to improve eye care.
Global Impact
We seek advances that can expand access to meaningful care.
